يعرض 121 - 140 نتائج من 29,992 نتيجة بحث عن '(( 09 1 decrease ) OR ( 50 ((((ns decrease) OR (nn decrease))) OR (we decrease)) ))', وقت الاستعلام: 0.55s تنقيح النتائج
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132
  13. 133

    Evaluation index results for the JS-10 phantom. حسب Masakazu Tsujimoto (22339504)

    منشور في 2025
    "…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …"
  14. 134

    NEMA IEC body phantom. حسب Masakazu Tsujimoto (22339504)

    منشور في 2025
    "…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …"
  15. 135

    Relationship between contrast, noise, and CNR. حسب Masakazu Tsujimoto (22339504)

    منشور في 2025
    "…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …"
  16. 136

    JS-10 phantom. حسب Masakazu Tsujimoto (22339504)

    منشور في 2025
    "…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …"
  17. 137

    The raw data used for the analyses in this study. حسب Masakazu Tsujimoto (22339504)

    منشور في 2025
    "…In the NEMA body phantom, contrast improved with acquisition times of ≥30 s/view, and the CNR increased as noise declined with longer acquisition times. At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. …"
  18. 138
  19. 139

    Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer حسب Fan-Fan Shang (16953264)

    منشور في 2023
    "…Cucurbitacin B (CuB) is a potent but toxic anticancer natural product. Herein, we designed and synthesized 2-OH- and 16-OH-modified CuB derivatives to improve their antitumor efficacy and reduce toxicity. …"
  20. 140